RNS Number : 8296A
Provexis PLC
15 October 2009
15 October 2009
Provexis plc
("Provexis" or the "Company")
Result of General Meeting
Provexis plc (PXS.L), the life-science business that discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies is pleased to announce that further to its announcement on 25 September 2009, all of the resolutions proposed at the General Meeting held earlier today were duly passed.
It is expected that the 159,030,610 new Ordinary Shares of 0.1p each in the Company subscribed for by new and existing shareholders at a price of 2.5p per share will be admitted to trading on AIM on 16 October 2009. Following Admission, the Company will have in issue 1,022,539,965 Ordinary Shares of 0.1p each.
Certain terms used in this announcement are defined and have the same meaning as in the Company's circular which was sent to shareholders on 28 September 2009.
ENQUIRIES
|
Provexis plc
|
Tel. 01753 752 290
|
|
Stephen Moon, Chief Executive
|
|
|
Ian Ford, Finance Director
|
|
|
|
|
|
Arbuthnot Securities Limited
|
Tel. 020 7012 2000
|
|
Tom Griffiths/Alasdair Younie
|
|
|
|
|
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMDGMMGLKDGLZG